Article type
Abstract
Background
Dengue, also known as break-bone fever, is a viral infection transmitted to humans by mosquitoes, primarily in tropical and subtropical regions. The global incidence of dengue has surged in recent decades, with reported cases to the World Health Organization (WHO) escalating from 505,430 in 2000 to 5.2 million in 2019. The WHO underscores the significance of conducting research in countries affected by the dengue epidemic to glean insights from successful interventions and integrate them into active surveillance strategies. This approach is paramount for generating evidence to inform public health policies and disease control strategies. Nevertheless, the dearth of comprehensive research reports in medical literature poses a challenge in evaluating the strengths and weaknesses of studies. It is imperative to identify potential inconsistencies in study reporting. The primary objective of the REporting of studies Conducted using Observational Routinely-collected health Data (RECORD) Statement framework is to bolster the quality of studies leveraging structured health-care data and foster confidence in their applicability for clinical decision-making. Against this backdrop, we propose a study aimed at analysing the quality of clinical research on dengue utilising the RECORD framework.
Methods
We conducted a scoping review to retrieve both observational studies and controlled trials focusing on prognosis for severe dengue. We searched the following sources from the inception of each database to the date of search and placed no restrictions on the language of publication: Medline (Ovid),Embase(Ovid) and Lilacs (BIREME). Specifically, studies using routinely collected health data as a data source (excluding those as part of an intervention or exposure) were targeted to assess RECORD adoption.
Results
At present, the study is ongoing, in the title and abstract screening phase of 154 studies retrieved. We expect to have the final results in August 2024.
Conclusions:
We expect to provide insights into the quality of clinical research on prognosis of severe dengue using the RECORD framework.
Dengue, also known as break-bone fever, is a viral infection transmitted to humans by mosquitoes, primarily in tropical and subtropical regions. The global incidence of dengue has surged in recent decades, with reported cases to the World Health Organization (WHO) escalating from 505,430 in 2000 to 5.2 million in 2019. The WHO underscores the significance of conducting research in countries affected by the dengue epidemic to glean insights from successful interventions and integrate them into active surveillance strategies. This approach is paramount for generating evidence to inform public health policies and disease control strategies. Nevertheless, the dearth of comprehensive research reports in medical literature poses a challenge in evaluating the strengths and weaknesses of studies. It is imperative to identify potential inconsistencies in study reporting. The primary objective of the REporting of studies Conducted using Observational Routinely-collected health Data (RECORD) Statement framework is to bolster the quality of studies leveraging structured health-care data and foster confidence in their applicability for clinical decision-making. Against this backdrop, we propose a study aimed at analysing the quality of clinical research on dengue utilising the RECORD framework.
Methods
We conducted a scoping review to retrieve both observational studies and controlled trials focusing on prognosis for severe dengue. We searched the following sources from the inception of each database to the date of search and placed no restrictions on the language of publication: Medline (Ovid),Embase(Ovid) and Lilacs (BIREME). Specifically, studies using routinely collected health data as a data source (excluding those as part of an intervention or exposure) were targeted to assess RECORD adoption.
Results
At present, the study is ongoing, in the title and abstract screening phase of 154 studies retrieved. We expect to have the final results in August 2024.
Conclusions:
We expect to provide insights into the quality of clinical research on prognosis of severe dengue using the RECORD framework.